Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024
Fri, September 13, 2024

Raghuram Selvaraju Reiterated (BBIO) at Strong Buy and Held Target at $43 on, Sep 17th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-43-on-sep-17th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $43 on, Sep 17th, 2024.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Raghuram


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, September 16th, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy and Held Target at $42 on, Wednesday, September 11th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $46 on, Wednesday, September 4th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024

Publication Contributing Sources